fbpx

Check out the latest episodes of our Life Science and Food Industry Podcasts. Available everywhere!

X

More Positive Data for Tirzepatide Weight Loss Injection + Sandoz’s Global Biosimilars Awareness Campaign – Xtalks Life Science Podcast Ep. 65

More Positive Data for Tirzepatide Weight Loss Injection + Sandoz’s Global Biosimilars Awareness Campaign – Xtalks Life Science Podcast Ep. 65

In this episode, Ayesha discussed new data shared by Eli Lilly for its weight loss injection tirzepatide. The drug was recently approved (under the brand name Mounjaro) by the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes. The dual GIP/GLP-1 receptor agonist also has weight loss effects and recent analyses presented at the American Diabetes Association’s 82nd Scientific Sessions showed that almost 40 percent of participants lost a quarter of their body weight. Hear more about the newest data and industry predictions for tirzepatide as a rival to Novo Nordisk’s GLP-1 receptor agonist weight loss injection Wegovy.

The editorial team also discussed a new global biosimilars awareness campaign launched by Sandoz, Novartis’ biosimilars and generics drug division. The campaign is called Act4Biosimilars and will focus on improving the acceptability and accessibility to biosimilars, among factors, by 30 percent in over 30 countries by the year 2030. The campaign is aimed at addressing global health inequity and inequality by increasing access to advanced medicines like biosimilars. The team discussed the importance of education around biosimilars to help increase their acceptability and uptake.

Listen on Apple Podcasts

Read the full articles here:

More Positive Data for Eli Lilly’s Diabetes and Weight Loss Injection Tirzepatide

Novartis’ Sandoz Launches Biosimilars Awareness Campaign to Improve Biosimilars Adoption Worldwide

The weekly podcast is available for streaming every Wednesday on SpotifyApple Music and wherever you stream your podcasts.

Subscribe to the Xtalks Life Science Podcast to never miss a new episode.